Ranbaxy joins hand with Cipla to co-market ciprofloxacin
Two of the leading pharmaceutical industries, Ranbaxy Laboratories and Cipla announced an alliance to co-market Ranbaxy’s once-a-day formulation of Ciprofloxacin. The formulation had recently received Drug Controller General of India’s (DCGIs) approval for marketing in India. Ciproloxacin is a unique dosage form of the broad-spectrum antibiotic. The domestic market for ciprofloxacin is estimated...Cipro Has Cheaper Cousins to Treat Anthrax
Cipro, Cipro, Cipro. That's been the mantra of the media as dozens of people exposed to anthrax -- and thousands who weren't -- clamor for the potent antibiotic. But if the supply dwindles, doctors say other cheaper and widely available medications can be used, including a previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is the latest and greatest, so it tends to...Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
Urinary tract infections (UTI) are often caused by bacteria and are frequently treated with antibiotics, such as fluoroquinolones. Fluoroquinolones have been recommended empirical therapy for treatment of complicated UTIs. Research indicates that Ciprofloxacin has high activity against E. coli that causes the majority of these infections. This new extended release formulation of ciprofloxacin may...